XORTX Therapeutics Inc
NASDAQ:XRTX

Watchlist Manager
XORTX Therapeutics Inc Logo
XORTX Therapeutics Inc
NASDAQ:XRTX
Watchlist
Price: 0.585 USD -0.85% Market Closed
Market Cap: 1.7m USD

Intrinsic Value

XRTX doesn't have a meaningful market cap.

The intrinsic value of one XRTX stock under the Base Case scenario is 0.537 USD. Compared to the current market price of 0.585 USD, XORTX Therapeutics Inc is Overvalued by 8%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

XRTX Intrinsic Value
0.537 USD
Overvaluation 8%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
XORTX Therapeutics Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about XRTX?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is XRTX valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for XORTX Therapeutics Inc.

Explain Valuation
Compare XRTX to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about XRTX?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
XORTX Therapeutics Inc

Current Assets 1.4m
Cash & Short-Term Investments 1.2m
Receivables 22.1k
Other Current Assets 141.5k
Non-Current Assets 1.5m
Long-Term Investments 1.2m
PP&E 59.6k
Intangibles 194k
Current Liabilities 837.4k
Accounts Payable 480.1k
Accrued Liabilities 197.3k
Other Current Liabilities 160k
Efficiency

Free Cash Flow Analysis
XORTX Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
XORTX Therapeutics Inc

Revenue
0 USD
Operating Expenses
-3.2m USD
Operating Income
-3.2m USD
Other Expenses
1.3m USD
Net Income
-1.9m USD
Fundamental Scores

XRTX Profitability Score
Profitability Due Diligence

XORTX Therapeutics Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
27/100
Profitability
Score

XORTX Therapeutics Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

XRTX Solvency Score
Solvency Due Diligence

XORTX Therapeutics Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
53/100
Solvency
Score

XORTX Therapeutics Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

XRTX Price Targets Summary
XORTX Therapeutics Inc

There are no price targets for XRTX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

XORTX Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for XRTX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one XRTX stock?

The intrinsic value of one XRTX stock under the Base Case scenario is 0.537 USD.

Is XRTX stock undervalued or overvalued?

Compared to the current market price of 0.585 USD, XORTX Therapeutics Inc is Overvalued by 8%.

Back to Top